By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company 20/20 Biolabs Inc.

20/20 Biolabs Inc. (AIDX)

NASDAQ Currency in USD
$464.00
-$8.57
-1.81%
Last Update: 18 Jul 2026, 12:43
$0.00
Market Cap
-421.82
P/E Ratio (TTM)
Forward Dividend Yield
$332.43-$640.29
52 Week Range

AIDX Stock Price Chart

Explore 20/20 Biolabs Inc. interactive price chart. Choose custom timeframes to analyze AIDX price movements and trends.

AIDX Company Profile

Discover essential business fundamentals and corporate details for 20/20 Biolabs Inc. (AIDX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

19 Feb 2026

Employees

14.00

CEO

Jonathan Cohen

Description

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

AIDX Financial Timeline

Browse a chronological timeline of 20/20 Biolabs Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 2 Sept 2026

EPS estimate is -$0.12, while revenue estimate is $636.00k.

Earnings released on 20 May 2026

EPS came in at -$0.28 falling short of the estimated -$0.10 by -180.00%, while revenue for the quarter reached $353.38k , missing expectations by -54.64%.

Earnings released on 31 Mar 2026

EPS came in at -$0.25 , while revenue for the quarter reached $538.00k .

AIDX Stock Performance

Access detailed AIDX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run